CADENCE PHARMACEUTICALS INC·4

May 20, 6:46 PM ET

Berman Michael A 4

4 · CADENCE PHARMACEUTICALS INC · Filed May 20, 2009

Insider Transaction Report

Form 4
Period: 2009-05-18
Transactions
  • Award

    Common Stock

    2009-05-18$9.58/sh+8,200$78,53331,500 total
Holdings
  • Common Stock

    (indirect: By Trust)
    800
  • Common Stock

    (indirect: By Spouse)
    3,000
  • Common Stock

    (indirect: By Trust)
    1,200
  • Common Stock

    (indirect: By Trust)
    900
Footnotes (2)
  • [F1]This transaction was executed in multiple trades at prices ranging from a low of $9.41 to a high of $9.68. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]Mr. Berman is a trustee of this trust.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION